SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    The US Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 11101117.
  • 2
    European FK506 Multicentre Liver Study Group. Randomized trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 1994; 344: 423427.
  • 3
    Adam R, McMaster P, O'Grady JG, Castaing D, Klempnauer JL, Jamieson N, et al. Evolution of Liver Transplantation in Europe: Report of the European Liver Transplant Registry. Liver Transplant 2003; 9 (12): 12311243.
  • 4
    Neuhaus P, Blumhardt G, Bechstein WO, Platz KP, Jonas S, Mueller AR, et al. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience. Transplantation 1995; 59: 3140.
  • 5
    Busutil RW, Farmer DG, Yersiz H, Hiatt JR, McDiarmid SV, Goldstein LI, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades. A single center experience. Ann Surg 2005; 241: 905916.
  • 6
    Jain A, Reyes J, Kashyap R, Dodson SF, Demetris AJ, Ruppert C, et al. Long-term survival after liver transplantation in 4000 consecutive patients at a single center. Ann Surg 2000; 232: 490500.
  • 7
    Abbasoglu O, Levy MF, Brkic BB, Testa G, Jeyarajah DR, Goldstein RM, et al. Ten years of liver transplantation: an evolving understanding of late graft loss. Transplantation 1997; 64: 18011807.
  • 8
    Zimmermann MA, Ghobrial RM. When shouldn't we retransplant? Liver Transpl 2005; 11: 1420.
  • 9
    Azoulay D, Lindhares MM, Huguet E, Delvart V, Castaing D, Adam R, et al. Decision for retransplantation of the liver. An experience and cost based analysis. Ann Surg 2002; 236: 713721.
  • 10
    Markmann JF, Markowitz JS, Yersiz H, Morrisey M, Farmer DG, Goss J, et al. Long-term survival after retransplantation of the liver. Ann Surg 1997; 226: 408418.
  • 11
    Doyle HR, Morelli F, McMichael J, Doria C, Aldrighetti L, Starzl TE, Marino IR. Hepatic retransplantation—an analysis of risk factors associated with outcome. Transplantation 1996; 61: 14991505.
  • 12
    Wong T, Devlin J, Rolando N, Heaton N, Williams R. Clinical characteristics affecting the outcome of liver retransplantation. Transplantation 1997; 64: 878882.
  • 13
    Facciuto M, Heidt D, Guarrera J, Bodian CA, Miller CM, Emre S, et al. Retransplantation for late liver graft failure: predictors of mortality. Liver Transpl 2000; 6: 174179.
  • 14
    Meneu-Diaz JC, Moreno Gonzales E, Moreno Elola-Olaso A, Lopez EV, Nuno Vasquez J, Jimenez C, et al. Liver recipients undergoing transplantation and subsequent retransplantation: a comparison between clinical characteristics. Hepatogastroenterology 2003; 50: 21432148.
  • 15
    Wang ZF, Liu C. Liver retransplantation: indications and outcomes. Hepatobiliary Pancreat Dis Int 2004; 3: 175178.
  • 16
    Durán FG, Cercadillo RA, Santos L, de Diego A, Ferreiroa J, Valdecantos E, Clemente G. Late orthotopic liver retransplantation: indications and survival. Transplant Proc 1998; 30: 18761877.
  • 17
    Kumar N, Wall WJ, Grant DR, Bloch M, Ghent CN, Adams PC, Marotta P. Liver Retransplantation. Transplant Proc 1999; 31: 541542.
  • 18
    Sanchez-Bueno F, Acosta F, Ramirez F, Robles R, Rodriguez JM, Munitiz V, et al. Incidence and survival rate of hepatic retransplantation in a series of 300 orthotopic liver transplants. Transplant Proc 2000; 32: 26712672.
  • 19
    De Carlis L, Slim AO, Giacomoni A, DiBenedetto F, Pirotta V, Lauterio A, et al. Liver Retransplantation: indications and results over a 15-year experience. Transplant Proc 2001; 33: 14111413.
  • 20
    Bilbao I, Figueras J, Grande L, Cleries M, Jaurrieta E, Visa J, Margarit C. Risk factors for death following liver retransplantation. Transplant Proc 2003; 35: 18711873.
  • 21
    Kashyap R, Jain A, Reyes J, Demetris AJ, Elmagd KA, Dodson SF, et al. Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up. Transplant Proc 2001; 33: 14861487.
  • 22
    Lerut J, Laterre PF, Roggen F, Mauel E, Gheerardyn R, Ciccarelli O, et al. Adult hepatic retransplantation. UCL experience. Acta Gastroenterol Belg 1999; 62: 261266.
  • 23
    Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, et al. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology 2004; 39: 230238.
  • 24
    Biggins SW, Beldecos A, Rabkin JM, Rosen HR. Retransplantation for hepatic allograft failure: Prognostic modeling and ethical considerations. Liver Transpl 2002; 8: 313322.
  • 25
    Ghobrial RM, Gornbein J, Steadman R, Danino N, Markmann JF, Holt C, et al. Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg 2002; 236: 315323.
  • 26
    Bilbao I, Armadans L, Lazaro JL, Hidalgo E, Castells L, Margarit C. Predictive factors for early mortality following liver transplantation. Clin Transplant 2003; 17: 401411.
  • 27
    Rosen HR, Prieto M, Taltavull TC, Cuervas Mons V, Guckelberger O, Muisan P, et al. Validation and refinement of survival models for liver retransplantation. Hepatology 2003; 38: 460468.
  • 28
    Postma R, Haagsma EB, Peeters PMJG, van den Berg AP, Slooff MJH. Retransplantation of the liver in adults: outcome and predictive factors of survival. Transplant Int 2004; 17: 234240.
  • 29
    Roayaie S, Schiano TD, Thung SN, Emre SH, Fishbein M, Miller CM, Schwartz ME. Results of retransplantation for recurrent hepatitis C. Hepatology 2003; 38: 14281436.
  • 30
    Watt KDS, Lyden ER, McCashland TM. Poor survival after liver retransplantation: is hepatitis C to blame? Liver Transpl 2003; 9: 10191024.
  • 31
    Barkmann A, Nashan B, Schmidt HHJ, Boker KH, Emmanouilidis N, Rosenau J, et al. Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil. Transplantation 2000; 69: 18861890.
  • 32
    Pfitzmann R, Klupp J, Langrehr JM, Uhl M, Neuhaus R, Settmacher U, et al. Mycophenolatemofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients. Transplantation 2003; 76: 130136.
  • 33
    Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation—a randomized, double-blind trial. Am J Transplant 2005; 5: 125130.